Novo Nordisk, a global leader in diabetes and obesity care, recently announced compelling Phase 2 trial results for its investigational…
Read More
Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025
Eli Lilly and Company has officially ascended to the pinnacle of the global pharmaceutical industry, concluding fiscal year 2025 as…
Read More
Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
In a groundbreaking development that could revolutionize the treatment of ocular cancers, researchers in China have successfully engineered eye drops…
Read More
Moving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D
Pharmaceutical research and development stands at a pivotal juncture, grappling with a paradoxical shift in drug modality approvals that signals…
Read More
Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.
Eli Lilly has made a historic leap, claiming the top position in the prestigious Pharma 50 ranking for 2026, a…
Read More
TrumpRx.gov: A Federal Portal’s Ambitions and the Intensifying Scrutiny of Direct-to-Consumer Drug Sales
As of early February, TrumpRx.gov presents a starkly minimalist facade: a stylized Oval Office portrait of the president accompanied by…
Read More
The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis
A paradigm shift in the understanding of GLP-1 receptor agonists, widely recognized as transformative agents in the battle against obesity…
Read More
Agentic AI-powered literature reviews: Reduce research burdens and accelerate insights
Literature reviews serve as an indispensable cornerstone in the rigorous landscape of drug development, providing the critical evidence base necessary…
Read More
Rubedo Life Sciences Charts Ambitious Course to Reverse Skin Aging and Disease Through Targeted Senescent Cell Clearance
In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…
Read More
JAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
A landmark prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has unveiled a compelling…
Read More
